Dr. James Summers Appointed to Mission Therapeutics’ Board of Directors

03:00 EDT 1 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Mission Therapeutics (“Mission”), a drug discovery and development company focused on treating mitochondrial diseases, fibrosis and neurodegenerative disorders by selectively inhibiting deubiquitylating enzymes (DUBs)...

Other Sources for this Article

Mission Therapeutics Ltd
Anker Lundemose MD PhD
Chief Executive Officer
T: +44 (0) 1223 607340

Instinctif Partners
Melanie Toyne-Sewell / Eileen Paul
T: +44 (0) 20 7457 2020


More From BioPortfolio on "Dr. James Summers Appointed to Mission Therapeutics’ Board of Directors"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...